QQQ   272.85 (+0.36%)
AAPL   457.16 (+1.13%)
MSFT   209.25 (+0.03%)
FB   260.76 (+0.33%)
GOOGL   1,524.26 (+1.13%)
AMZN   3,205.09 (+1.36%)
NVDA   463.50 (+1.29%)
CGC   17.44 (+1.10%)
BABA   253.39 (-0.71%)
TSLA   1,607.64 (+3.40%)
GE   6.67 (-0.74%)
MU   46.66 (-3.75%)
AMD   82.47 (-0.17%)
T   30.02 (-0.53%)
F   7.14 (+0.42%)
ACB   9.69 (-1.12%)
GILD   68.33 (-0.74%)
NFLX   477.14 (+0.35%)
DIS   131.85 (+0.05%)
BAC   26.37 (-1.35%)
BA   177.79 (+1.34%)
QQQ   272.85 (+0.36%)
AAPL   457.16 (+1.13%)
MSFT   209.25 (+0.03%)
FB   260.76 (+0.33%)
GOOGL   1,524.26 (+1.13%)
AMZN   3,205.09 (+1.36%)
NVDA   463.50 (+1.29%)
CGC   17.44 (+1.10%)
BABA   253.39 (-0.71%)
TSLA   1,607.64 (+3.40%)
GE   6.67 (-0.74%)
MU   46.66 (-3.75%)
AMD   82.47 (-0.17%)
T   30.02 (-0.53%)
F   7.14 (+0.42%)
ACB   9.69 (-1.12%)
GILD   68.33 (-0.74%)
NFLX   477.14 (+0.35%)
DIS   131.85 (+0.05%)
BAC   26.37 (-1.35%)
BA   177.79 (+1.34%)
QQQ   272.85 (+0.36%)
AAPL   457.16 (+1.13%)
MSFT   209.25 (+0.03%)
FB   260.76 (+0.33%)
GOOGL   1,524.26 (+1.13%)
AMZN   3,205.09 (+1.36%)
NVDA   463.50 (+1.29%)
CGC   17.44 (+1.10%)
BABA   253.39 (-0.71%)
TSLA   1,607.64 (+3.40%)
GE   6.67 (-0.74%)
MU   46.66 (-3.75%)
AMD   82.47 (-0.17%)
T   30.02 (-0.53%)
F   7.14 (+0.42%)
ACB   9.69 (-1.12%)
GILD   68.33 (-0.74%)
NFLX   477.14 (+0.35%)
DIS   131.85 (+0.05%)
BAC   26.37 (-1.35%)
BA   177.79 (+1.34%)
QQQ   272.85 (+0.36%)
AAPL   457.16 (+1.13%)
MSFT   209.25 (+0.03%)
FB   260.76 (+0.33%)
GOOGL   1,524.26 (+1.13%)
AMZN   3,205.09 (+1.36%)
NVDA   463.50 (+1.29%)
CGC   17.44 (+1.10%)
BABA   253.39 (-0.71%)
TSLA   1,607.64 (+3.40%)
GE   6.67 (-0.74%)
MU   46.66 (-3.75%)
AMD   82.47 (-0.17%)
T   30.02 (-0.53%)
F   7.14 (+0.42%)
ACB   9.69 (-1.12%)
GILD   68.33 (-0.74%)
NFLX   477.14 (+0.35%)
DIS   131.85 (+0.05%)
BAC   26.37 (-1.35%)
BA   177.79 (+1.34%)
Log in

NYSE:AVNSAvanos Medical Stock Price, Forecast & News

$33.00
+0.20 (+0.61 %)
(As of 08/13/2020 11:09 AM ET)
Add
Compare
Today's Range
$32.58
Now: $33.00
$33.00
50-Day Range
$27.33
MA: $30.64
$33.19
52-Week Range
$19.46
Now: $33.00
$48.07
Volume851 shs
Average Volume373,109 shs
Market Capitalization$1.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.18
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes. The company also offers Game Read, a product for pain management and rehabilitation of patients recovering from orthopedic surgery or sports-related injuries; GRPro 2.1, a cold and compression therapy system; Med4Elite, a multi-modality therapy unit; ATX Wraps; and various product accessories. In addition, it sells its products under the ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY brand names. The company markets its products directly to hospitals and other healthcare providers, as well as through third-party distribution channels. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Read More
Avanos Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.21 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-428-2667

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$697.60 million
Cash Flow$1.94 per share
Book Value$26.38 per share

Profitability

Net Income$-45,900,000.00

Miscellaneous

Employees4,700
Market Cap$1.58 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$33.00
+0.20 (+0.61 %)
(As of 08/13/2020 11:09 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avanos Medical (NYSE:AVNS) Frequently Asked Questions

How has Avanos Medical's stock price been impacted by COVID-19 (Coronavirus)?

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AVNS shares have increased by 13.8% and is now trading at $33.00.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Avanos Medical?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Avanos Medical
.

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Avanos Medical
.

How were Avanos Medical's earnings last quarter?

Avanos Medical Inc (NYSE:AVNS) issued its quarterly earnings data on Tuesday, August, 4th. The company reported $0.13 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.10) by $0.23. The company earned $163.70 million during the quarter, compared to analysts' expectations of $147.90 million. Avanos Medical had a negative net margin of 2.40% and a positive return on equity of 3.52%. The business's revenue was down 4.9% on a year-over-year basis. During the same quarter last year, the business posted $0.28 EPS.
View Avanos Medical's earnings history
.

What price target have analysts set for AVNS?

7 brokers have issued 12 month price targets for Avanos Medical's stock. Their forecasts range from $30.00 to $43.00. On average, they anticipate Avanos Medical's stock price to reach $33.20 in the next twelve months. This suggests a possible upside of 0.6% from the stock's current price.
View analysts' price targets for Avanos Medical
.

Has Avanos Medical been receiving favorable news coverage?

Media headlines about AVNS stock have been trending extremely negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avanos Medical earned a media sentiment score of -4.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next several days.
View the latest news about Avanos Medical
.

Are investors shorting Avanos Medical?

Avanos Medical saw a decrease in short interest during the month of February. As of February 15th, there was short interest totaling 2,910,000 shares, a decrease of 11.3% from the January 31st total of 3,280,000 shares. Based on an average daily trading volume, of 365,300 shares, the short-interest ratio is presently 8.0 days. Approximately 6.1% of the company's shares are sold short.
View Avanos Medical's Short Interest
.

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), Procter & Gamble (PG), CVS Health (CVS), Honeywell International (HON), Alibaba Group (BABA), Pfizer (PFE), AT&T (T), Johnson & Johnson (JNJ), Verizon Communications (VZ) and Abbott Laboratories (ABT).

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the following people:
  • Mr. Joseph F. Woody, CEO & Director (Age 53)
  • Mr. John W. Wesley, Sr. VP of Legal & Gov. Relations (Age 60)
  • Mr. John R. Tushar, Pres of Global Franchises (Age 57)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 53)
  • Mr. Warren J. MacHan, Sr. VP of Bus. Strategy & Interim CFO (Age 53)

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Paradice Investment Management LLC (5.55%), Victory Capital Management Inc. (4.08%), Macquarie Group Ltd. (3.49%), Goldman Sachs Group Inc. (3.32%), Bank of New York Mellon Corp (1.18%) and Confluence Investment Management LLC (1.16%). Company insiders that own Avanos Medical stock include Gary Blackford, John W Wesley, Joseph Fralin Woody and Steven E Voskuil.
View institutional ownership trends for Avanos Medical
.

Which institutional investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Prudential Financial Inc., Oppenheimer Asset Management Inc., Russell Investments Group Ltd., Palmer Knight Co, Texas Permanent School Fund, American International Group Inc., and S.A. Mason LLC.
View insider buying and selling activity for Avanos Medical
.

Which institutional investors are buying Avanos Medical stock?

AVNS stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Goldman Sachs Group Inc., Macquarie Group Ltd., Paradice Investment Management LLC, SG Americas Securities LLC, Heartland Advisors Inc., Swiss National Bank, and Alberta Investment Management Corp. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, John W Wesley, Joseph Fralin Woody, and Steven E Voskuil.
View insider buying and selling activity for Avanos Medical
.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $33.00.

How big of a company is Avanos Medical?

Avanos Medical has a market capitalization of $1.58 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

What is Avanos Medical's official website?

The official website for Avanos Medical is avanos.com.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.